The content is available as a PDF (524.5 KB).
letter . 2020 Aug 11:ciaa1191. doi: 10.1093/cid/ciaa1191
Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target?
Emily Klann
1,2,✉, Shannan Rich
1,2, Volker Mai
1,2
Emily Klann, MPH
1
Department of Epidemiology, University of Florida, Gainesville, Florida, United States
2
Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States
Find articles by Emily Klann
Shannan Rich, MSE
1
Department of Epidemiology, University of Florida, Gainesville, Florida, United States
2
Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States
Find articles by Shannan Rich
Volker Mai, PhD, MPH
1
Department of Epidemiology, University of Florida, Gainesville, Florida, United States
2
Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States
Find articles by Volker Mai
1
Department of Epidemiology, University of Florida, Gainesville, Florida, United States
2
Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States
✉
Corresponding author contact information: Name: Emily Klann, Institution address: 2055 Mowry Road, University of Florida, Gainesville, FL, 32611, USA, Phone number: (724) 256-0359, Email: emilyklann@ufl.edu
Received 2020 Jul 28.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7454358 PMID: 32780788
See commentary "Reply to Klann et al." with doi: 10.1093/cid/ciaa1194.